Targeted Cancer Therapy NewsLatest News On Targeted Cancer Therapy Does Combination Therapy Increase Infection Risk in PsA?8/25/2025 9:31 AM Bladder Cancer: 5 Things to Know8/19/2025 11:54 PM Balancing Benefit and Risk: Optimizing Systemic Therapies for HR+ Early-Stage Breast Cancer8/13/2025 12:56 PM Oncology’s Side Effect Disconnect: The Messy Reality8/5/2025 3:54 AM EMA Greenlights Voranigo for IDH-Mutant Grade 2 Glioma7/28/2025 11:32 AM Real-World Data: Adjuvant Therapy for BRAF-Mutated Melanoma7/8/2025 12:28 PM Autoimmune Skin Diseases Linked to Better Survival in Patients With Cancer After Rx7/4/2025 1:54 AM Melanoma Updates From ASCO 2025 Focus on Resistance and Refinement7/3/2025 12:46 PM Emerging Themes in GI Oncology from ASCO 20257/1/2025 4:44 PM Sclerosing Mesenteritis: What GIs Need to Know About This Rare Disease6/27/2025 7:31 AM
